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Pretrial Drug Testing-An Essential Component
of the National Drug Control Strategy
Reggie B. Walton*
Gary J. Peters**
J. Anthony Towns***
When President George Bush unveiled the first National
Drug Control Strategy in September 1989, he emphasized that
combatting drug abuse and drug trafficking was the number
one priority on his domestic affairs agenda. 1 The President's
emphasis on this tragic and terribly destructive problem was
consistent with its importance in the public's mind, as reflected
in numerous polls and surveys. The President has continually
reiterated the importance he attaches to the Nation's counterdrug efforts, and while opinion polls may now show other
problems to be paramount in the public's mind, the drug
problem remains a vital concern. 2

* Reggie B. Walton received his Juris Doctorate from the American
University, Washington College of Law. He served as Associate Judge and Deputy
Presiding Judge of the Criminal Division of the Superior Court of the District of
Columbia. In 1989, he was appointed by President Bush to be the Associate
Director of the Office of National Drug Control Policy, where he headed the
Bureau of State and Local Affairs. In May of 1991, he was appointed as Senior
White House Advisor for Crime. He served in that position until December of 1991,
when he returned to the Superior Court where he now serves as an Associate
Judge.
** Gary J. Peters received his Juris Doctorate, from the University of
Michigan Law School and is the Bureau of State and Local Affair's Special
Assistant for Law Enforcement and Criminal Justice.
*** J. Anthony Towns received his Juris Doctorate from Georgetown University
Law Center and is currently Judge Walton's law clerk.
1.
In his Inaugural Address (January 20, 1989), President Bush said, "There
are few clear areas in which we as a society must rise up united and express our
intolerance. The most obvious now is drugs. And when that first cocaine was
smuggled in on a ship, it may as well have been a deadly bacteria, so much has it
hurt the body, the soul of our country. And there is much to be done and to be
said, but take my word for it: This scourge will stop!" 1 PUB. PAPERS 3 (1989).
2.
See, e.g., The New York Times/CBS News Poll, N.Y. TIMES, Sept. 6, 1990,
at A22.
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This article addresses only one of the many weapons the
United States has and needs in its arsenal to effectively combat
the scourge of drugs: the expanded use of drug testing in the
criminal justice system, and in particular, testing during the
pretrial stage of the process. Such drug testing through
urinalysis has been encouraged in each of the National Drug
Control Strategies issued to date. This position is consistent
with other themes incorporated in those Strategies and with
the Constitutional protections provided by the Fourth, Fifth,
and Sixth Amendments. 3 As such, the use of drug testing as a
part of the criminal justice system should be further expanded
at the Federal, State and local levels. While this article
confines itself primarily to the limited arena of pretrial drug
testing, it should be noted that the Bush Administration has
also encouraged the use of drug testing throughout the criminal
justice process and also in the workplace, in both the public
and private sectors. 4
I. THE NATIONAL DRUG CONTROL STRATEGY'S EMPHASIS ON
DRUG TESTING IN THE CRIMINAL JUSTICE SYSTEM

The third edition of the National Drug Control Strategy,
prepared by the Office of National Drug Control Policy
(ONDCP) was issued by President Bush on January 31, 1991.
Like its predecessors, the Strategy presents a comprehensive
approach to controlling both the supply of illicit drugs and the
demand for them. The Strategy sets policies and encourages
measures designed to implement those policies in each of seven
priority subject areas: (1) the Criminal Justice System; (2)
Drug Treatment; (3) Education, Community Action, and the
Workplace; (4) International Initiatives; (5) Interdiction Efforts;
(6) Research; and (7) Intelligence.
Certain themes are consistently emphasized throughout
these different priority subject areas, including that of
accountability. For too long in this country, both drug offenders
and many of the programs designed to apprehend, prosecute,
punish or treat them have been able to avoid accountability. To

3.
See discussion infra part III.
4.
THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY, 70-73, 149 (1991)
(hereinafter NATIONAL DRUG CONTROL STRATEGY Ill); OFFICE OF NATIONAL DRUG
CONTROL POLICY, STATE DRUG CONTROL STATUS REPORT (WHITE PAPER) 17-18
(1990) (hereinafter STATUS REPORT); OFFICE OF NATIONAL DRUG CONTROL POLICY,
BUILDING A DRUG-FREE WORKPLACE (GUIDE FOR STATE LEGISLATION) (1990).
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address this deficiency, the Strategy has encouraged, among
other measures: new and different kinds of accountability, so
that all drug offenders, casual and occasional users as well as
dealers, can be held responsible for their aberrant behavior;
evaluations of the effectiveness of anti-drug programs (whether
oriented towards law enforcement, prevention, treatment, or
corrections) receiving Federal grant dollars; and the expanded
use of quantified and scheduled objectives to better assess
longitudinal program effectiveness.
There are a number of specific policies and programs
encouraged in the National Drug Control Strategy that reflect
this principle of accountability. One such policy that the Bush
Administration has promoted from its inception has been the
expanded use of drug testing in the criminal justice system.
The initial Strategy, issued by President Bush on September 5,
1989, called for drug testing at every stage of the criminal
justice process. 5 A few months later, on January 25, 1990,
President Bush's Second National Drug Control Strategy was
issued. It, too, called for drug testing through urinalysis within
the criminal justice system for those on pretrial and postconviction release. 6 Like its predecessors, the Third Strategy
calls for the use of drug testing through urinalysis at all stages
of the criminal justice process, from the time of arrest through
parole. 7
Following publication of the initial Strategy, the
Administration proposed legislation that would have
conditioned receipt of Federal criminal justice funds upon
States adopting drug testing programs for targeted classes of
individuals throughout their criminal justice systems. 8 While
Congress has not yet enacted the legislation, the
Administration continues to support this requirement and will
pursue its enactment. 9
5.
THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY 26, 100 (1989)
[hereinafter NATIONAL DRUG CONTROL STRATEGY I].
6.
THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY 25-26 (1990)
[hereinafter NATIONAL DRUG CONTROL STRATEGY II]. The President submits a new
National Drug Control Strategy to Congress by February 1 of each year, as
required by Section 1005 of the Anti-Drug Abuse Act of 1988, Public L. No. 100690, 102 Stat. 4181 (codified at 21 U.S.C. §§ 1502, 1504 (1988)). To date, each
volume of the Strategy has reaffirmed-and then built upon-the policies set forth
in the initial Strategy. See NATIONAL DRUG CONTROL STRATEGY II, supra, at 6;
NATIONAL DRUG CONTROL STRATEGY III, supra note 4, at 2-3.
NATIONAL DRUG CONTROL STRATEGY III, supra note 4, at 34.
7.
8.
S. 1711, lOlst Cong., 1st Sess. (1989).
NATIONAL DRUG CONTROL STRATEGY III, supra note 4, at 34. On March 11,
9.
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Drug testing programs can improve counter-drug efforts,
and the accountability of those efforts, in a number of
overlapping areas. For example, they serve as an "early
warning system" that provides another method of monitoring
pretrial and post-conviction releasees. Those who violate the
conditions of their release by continued drug use can be
detected quickly and sanctioned. Test results can also help
judges allocate scarce treatment slots to those who need them
most. Moreover, such testing programs, accompanied by swift
and certain penalties for continued drug use in violation of a
condition of community release, can provide an incentive for
criminal defendants to get off, and stay off, illegal drugs.
II.

DRUG USE AND ITS RELATIONSHIP TO CRIME AND FAILURE
TO APPEAR FOR FUTURE COURT PROCEEDINGS

A. Drug Use and Crime
The government has a legitimate interest both in preventing crime and in securing the appearance of charged offenders
at future court proceedings. 10 In turn, the legitimacy of required urinalysis programs, at least at the pretrial stage, depends on whether the procedure is reasonably related to furthering those interests. u There is substantial evidence of such
a relationship.
In 1986, a panel of criminal justice professionals convened
by the National Research Council of the National Academy of
Sciences concluded that while the connection may be a complex
one, "[t]he relationship between substance abuse and criminal
activity is widely thought to be firmly established, supported by
empirical research as well as informal observations of criminal
justice operations." 12 A 1986 United States Department of
Justice survey of State prison inmates showed that one in three
offenders was under the influence of some drug when they
committed the offense for which they had been charged. For
1991, the Administration's drug testing proposal for criminal justice systems was
submitted as part of the Comprehensive Violent Crime Control Act of 1991, S. 635,
102d Cong., 1st Sess. §§ 901-902.
10.
Richard B. Abell, Pretrial Drug Testing: Expanding Rights and Protecting
Public Safety, 57 GEO. WASH. L. REV. 943, 945, 950 (1989).
11.
ld.
12.
PANEL ON RESEARCH ON CRIMINAL CAREERS, NATIONAL ACADEMY OF SC!ENC·
ES 50 (A. Blumstein et al. eds., 1986). While serving as an Associate Judge on the
District of Columbia's Superior Court, one of the co-authors of this article, Reggie
B. Walton, was a member of this Panel.
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certain offenses, the rates were even higher. 13 Numerous other studies conducted over the last decade have shown that drug
involved offenders commit crimes with much greater frequency
than offenders who are not drug users. 14 These crimes include
not only continued drug violations and property-related offenses, but violent crimes as well. This is illustrated by the toxicology data of the victims and the urinalysis test results of the
assailants involved in the 435 homicides which occurred in the
District of Columbia from January 1 to November 30, 1990,
which indicated that most of the victims and the assailants had
drugs in their systems at the time of their deaths or arrests. 15
The Drug Use Forecasting (DUF) System, established by
the National Institute of Justice, reveals that drug use is far
more prevalent among arrestees, as compared to the non-arrestee population. Since 1986, the DUF program has used random and voluntary urinalyses to test a sample of arrestees in
selected major cities to determine recent drug use. By 1990,
twenty-three cities had entered the DUF program, in which
arrestees' urine samples are tested for the presence of ten different drugs (including cocaine, marijuana, phencyclidine-PCP,
methamphetamine, heroin, and opium), and a report of the
findings is released each quarter. 16 Admittedly, the DUF data
does not reveal whether the user's need for drugs was a motive
for the commission of the offense charged, or whether the arrestee was a chronic or an occasional userY Nevertheless, it
is significant that the DUF program determines drug use pri-

13.
BUREAU OF JUSI'ICE STATISTICS, U.S. DEP'r OF JUSTICE, STATE PRISON
INMATE SURVEY, 1986: DRUG USE AND CRIME 3-4 (1988).
14.
See Christy A. Visher, Using Drug Testing to Identify High-Risk Defendants
on Release: A Study in the District of Columbia, 18 J. CRIM. JUST. 321 (1990); see
also MARY G. GRAHAM, U.S. DEP'T OF JU&'TICE, CONTROLLING DRUG ABUSE AND
CRIME: A RESEARCH UPDATE (1987); BERNARD A. GROPPER, U.S. DEP'T OF JUSI'ICE,
PROBING THE LINKS BETWEEN DRUGS AND CRIME (1985); James Q. Wilson, Drugs
and Crime, in 13 DRUGS AND CRIME 521, 522 (Michael Tonry & Norval Morris
eds., 1990) James K. Stewart, Quid Pro Quo: Stay Drug-Free and Stay on Release,
57 GEO. WASH. L. REV. 68, 69 (1988).
15.
STATISTICAL ANALYSIS CENTER, OFFICE OF CRIMINAL JUSTICE PLANS AND
ANALYSIS, DISTRICT OF COLUMBIA, DRUG ABUSE INDICATORS TREND REPORT FOR THE
DISTRICT OF COLUMBIA (1991); see also Jan M. Chaiken & Marcia R. Chaiken,
Drugs and Predatory Crime, in 13 DRUGS AND CRIME 203, 205, 212-13 (Michael
Tonry & Norval Morris eds., 1990); Stewart, supra note 14, at 69.
16.
See, e.g., NATIONAL INST. OF JUSTICE, U.S. DEP'T OF JUSI'ICE, ARRESI'EE
DRUG USE, JANUARY TO MARCH 1990 (1990).
Eric D. Wish & Bernard A. Gropper, Drug Testing by the Criminal Justice
17.
System: Methods, Research, and Applications, in 13 DRUGS AND CRIME 321, 369
(Michael Tonry & Norval Morris eds., 1990).
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marily through urinalysis, which has proven to be a far more
reliable method than self-reporting. 18 Moreover, the DUF program focuses on drug use among those charged with crimes, a
population that is underrepresented in other drug use surveys,
such as the National Institute on Drug Abuse's National
Household Survey. By using urinalysis to test a sample of those
arrested in major cities, the DUF program provides concrete
information about a subsection of the population where drug
use is heavily concentrated. Indeed, the results of the DUF
program to date reveal that the rate of drug use is as much as
ten times greater among those arrested for serious crimes, as
compared to those in the general population. 19

B. Drug Use and Failure to Appear
At least one judge who has previously written about pretrial drug testing has noted that assuring defendants' appearances at future court proceedings is a compelling govemmental
concem. 2° Clearly, this position is correct. When defendants
fail to reappear for court proceedings, the criminal justice process, under most circumstances, cannot go forward. This causes
substantial inconvenience to not only the court and the attorneys, but perhaps more importantly, to the victims of crime. In
addition, public funds are lost every time a case has to be extended to apprehend defendants who fail to come to court.
It has been shown that drug use also has a negative effect
on the reappearance rate of arrestees. In the District of Columbia, for example, researchers found, after screening for other
factors that might affect pretrial release risk such as background characteristics and prior record, that defendants identified through urine tests as recent drug users pose higher
pretrial release risks than nonusers, both for failure to appear

18.
During an eight-month (June 1984-Jan. 1985) study of arrestees in the
District of Columbia, less than one-half of the drug users identified by urine tests
told researchers they were drug users. MARY A. TOBORG ET AL., U.S. DEP'T OF
JUSTICE, ASSESSMENT OF PRETRIAL URINE TESTING IN THE DISTRICT OF COLUMBIA 5
(1989). Similar results were obtained from a comparative study of urinalysis and
self-reporting involving arrestees in New York City. Eric D. Wish & Bruce D.
Johnson, The Impact of Substance Abuse on Criminal Careers, in 2 CRIMINAL CAREERS AND "CAREER CRIMINALS" 70 (Alfred Blumstien et al. eds., 1986).
OFFICE OF NATIONAL DRUG CONTROL POLICY, LEADING DRUG INDICATORS
19.
(WHITE PAPER) 16-19 (1990).
JUDGE ROBERT L. EVANS, RECORDER'S COURT FOR THE CITY OF D~<,'TROIT,
20.
DRUG TESTING WITHIN THE CRIMINAL JUSTICE SYSTEM: Is IT CONSTITUTIONAL?
(MONOGRAPH) 12 (1988).
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and pretrial rearrest.:l 1 A study of 2,606 New York City
arrestees reached similar conclusions regarding the utility of
urine test results in improving pretrial risk classification. 22 It
found that positive drug results were "significantly associated"
with both failure to appear and the probability of rearrest. 23
The New York City study also corroborated findings from
the District of Columbia program that the use of specific drugs
and the use of a combination of drugs relate in different ways
to the risks of pretrial arrest, failure to appear, or overall pretrial misconduct (a composite measure used by the researchers,
consisting of failure to appear, pretrial rearrest, or both). Those
who tested positive for cocaine and/or heroin were found to be
more likely to fail to appear, while those testing positive for
PCP or a combination of three or more drugs were more likely
to be arrested during the pretrial period. 24 A third study conducted by the National Institute of Justice, using data from
New York and Washington, also concluded that defendants
with positive drug tests at the time of their arrest, especially
for several drugs, are more likely to be rearrested before trial
and more likely to fail to appear than arrestees with similar
profiles whose urine tests were negative. 25
Moreover, defendants who "participated" in Washington's
pretrial urine-testing program-arrestees tested on four or
more occasions following their arrests (the lockup test plus at
least three subsequent tests)-performed significantly better on
pretrial release than other released defendants, while those

TOBORG ET AL., supra note 18, at 18.
Douglas A. Smith et a!., Drug Use and Pretrial Misconduct in New York
City, 5 J. QUANTITATIVE CRIMINOLOGY 101 (1989).
!d. at 122-23; see also Cathryn Jo Rosen & John S. Goldkamp, The Consti23.
tutionality of Drug Testing at the Bail Stage, 80 J. CRIM. L. & CRIMINOLOGY 114,
165 (1989). ("Preliminary research provides empirical evidence tending to show a
connection between positive results in bail stage urine testing and performance on
pretrial release.") (footnote omitted). However, in Smith et al., supra note 22, at
121-22, the same authors question the empirical support of the general relationship
between drug use and crimes committed by individuals on pretrial release.
24.
Smith et al., supra note 22, at 124; TOBORG ET AL., supra note 18, at 10.
25.
Christy A. Visher & Richard L. Linster, A Survival Model of Pretrial
Failure, 6 J. QUANTITATIVE CRIMINOLOGY 153 (1990); Christy A. Visher, Incorporating Drug Treatment in Criminal Sanctions, N.I.J. REP., Summer 1990, at 2 n.2.
However, the author notes that in two other jurisdictions (Miami and Tucson),
drug test results did not appear strongly related to rearrest or failure-to-appear
rates, an inconsistency which she suggests may be explained by differences in
study design and analysis and also by different patterns of drug use. !d. at 2-3, 7
n.3.
21.
22.
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who did not comply with pretrial testing orders did notably
worse. 26 Indeed, both the rates of pretrial rearrest and failure
to appear for defendants who participated in the
program-about two-thirds of all persons ordered into the
programs-were about one-half the rates of the defendants who
did not participate. 27 Thus, not only can initial lockup urine
tests help classify defendants for pretrial release risks, but the
nature of defendants' participation in the pretrial urine testing
program after release can also help to assess pretrial release
risks after enrollment in the program. 28
Judges in the District of Columbia recognize and appreciate the utility of this potential "signaling" effect of drug testing
for pretrial monitoring purposes. When asked about the effects
of the testing program on rates of failure to appear and pretrial
rearrest, most judges thought both rates were lower than they
would be without the program and that a defendant's performance in the program (both in terms of test results and test
participation) served as a good "signal" or indicator with respect to both risks, particularly with respect to failures to appear.29
Ill.

PRETRIAL DRUG TESTING AND THE CONSTITUTIOW0

Despite the obvious benefits that can be derived from pretrial drug testing, legal opposition to the procedure still exists.

26.
TOBORG ET AL., supra note 18, at 18.
TOBERG ET AL., supra note 18, at 18.
27.
28.
TOBORG ET AL., supra note 18, at 18.
29.
TOBORG ET AL., surpa note 18, at 13; see also MARY A. TOBORG & JOHN P.
BELLASSAI, U.S. DEP'T OF JUSTICE, PRETRIAL URINE TESTING IN THE DISTRICT OF
COLUMBIA: THE PERSPECTIVES OF JUDICIAL OFFICERS IN 1989 28-29 (1989)
(available from the National Criminal Justice Reference Service, Rockville, Maryland); MARY A. TOBORG ET AL., ASSESSMENT OF PRETRIAL URINE TESTING IN THE
DISTRICT OF COLUMBIA: PERIODIC URINE TESTING AS A SIGNALING DEVICE FOR PRETRIAL RELEASE (MONOGRAPH 5) (1989) [herinafter PRETRIAL RELEASE].
30.
In part V, infra, we also recognize the utility of post-conviction drug
testing-where fewer constitutional protections exist-including a diminished expectation of privacy, than in the pretrial setting. See, e.g., United States v. Williams, 787 F.2d 1182, 1185 (7th Cir. 1986); Storms v. Coughlin, 600 F. Supp. 1214,
1221 (S.D.N.Y. 1984); see also Griffin v. Wisconsin, 483 U.S. 868, 874 (1987); Bell
v. Wolfish, 441 U.S. 520 (1979); Campbell v. McGruder, 580 F.2d 521 (D.C. Cir.
1978); WAYNE R. LAFAVE, 4 SEARCH AND SEIZURE-A TREATISE ON THE FOURTH
AMENDMENT §§10.9-10.10 (2d ed. 1987). But see Cathryn Jo Rosen, The Fourth
Amendment Implications of Urine Testing for Evidence of Drug Use in Probation,
55 BROOK. L. REV. 1159, 1182 n.97, 1213-15, 1226-28, 1239 (1990). The weight of
authority supports the Administration's view that post-conviction drug testing is
both a legally accepted and an effective component of the criminal justice system.
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The legal arguments advanced in opposition to pretrial testing
are numerous. 31 They include: (1) that pretrial drug testing
amounts to a substantive due process violation because it places an unreasonable condition of release on arrestees; (2) that
the testing procedures are not sufficiently reliable to meet the
constitutional requirements of procedural due process; (3) that
pretrial drug testing constitutes a violation of the Fourth
Amendment proscription against unreasonable searches and
seizures; (4) that pretrial drug testing violates the constitutional privilege against self incrimination guaranteed by the Fifth
Amendment; and (5) that the procedure deprives arrestees of
their Sixth Amendment right to counsel. 32 However, none of
these arguments is sufficiently compelling to render pretrial
testing unconstitutional. 33

A.

The Substantive Due Process Argument

In Bell v. Wolfish, 34 the Supreme Court held that the
Fifth Amendment's Due Process Clause (made applicable to the
States by the Fourteenth Amendment) protects arrestees from
being punished prior to an adjudication of guilt. 35 Thus, in
viewing the constitutionality of conditions of pretrial release,
the appropriate inquiry centers on whether the conditions of
release amount to punishment of the arrestee. 36 Specifically,
the Supreme Court held "that in determining whether a governmental action is considered punishment in the constitutional sense of the word a court must decide whether the disability
is imposed for the purpose of punishment or whether it is but
an incident of some other legitimate governmental purpose."37
Previously, the Supreme Court had held that the substantive

31.
See generally Rosen & Goldkamp, supra note 23, at 114.
32.
A District of Columbia study in which twenty-five judges and commissioners
were interviewed showed that pretrial drug testing actually enhanced Eighth
Amendment bail rights. This salutary result occurs because drug testing affords
arrestees who are drug users the option of being placed on pretrial release without
posting a monetary bond, provided that they submit to continued urine test monitoring following their release. See Abell, supra note 10, at 956 (citing TOBORG &
BEUASSAI, supra note 29, at 17).
See EvANS, supra note 20, at 17; Abell, supra note 10, at 945-946; Charles
33.
J. Cooper, The Constitutionality of Drug Testing, 35 FED. BAR NEWS J. 359 (1988);
Stewart, supra note 14, at 74-75.
34.
441 U.S. 520 (1979).
35.
ld. at 535.
36.
ld.
37.
ld. at 538.
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due process analysis requires courts to assess "whether there is
an alternative purpose to which [the condition of release] may
rationally be connected, and whether the procedure under review appears excessive in relation to the alternative purpose."38 So long as a particular "condition or restriction" is
reasonably related to a legitimate government objective, the
Supreme Court has held that it does not, without more,
amount to "punishment."39 On the other hand, if the restriction or condition is not "reasonably related to a legitimate
goal-if it is arbitrary or purposeless-a court permissibly may
infer that the purpose of the governmental action is punishment."40
Consistent with the holding in Bell, the Federal Bail Reform Act of 1984 (Act)41 has been held to authorize courts to
detain arrestees charged with certain serious felonies if the
government demonstrates by "clear and convincing evidence"
after an adversary hearing, that no release conditions "will
reasonably assure the safety of any other person and the community."42 While the Act grants courts the authority to detain
arrestees prior to trial, it also gives them the authority to place
conditions and restrictions on arrestees who are released. 43
Accordingly, the Supreme Court has held that "pretrial release
may be accompanied by burdensome conditions that effect a
significant restraint on liberty."44
As discussed in Part II, supra, there is a direct correlation
between drug use and the increased likelihood that defendants
will fail to appear for future court proceedings, be rearrested,
or both. The substantive due process test articulated in Bell is
satisfied by this nexus. 45

38.
Kennedy v. Mendoza-Martinez, 372 U.S. 144, 168-69 (1963).
39.
Bell, 441 U.S. at 539.
40.
ld.
41.
18 U.S.C. §§ 3141 -3156 (Supp. III 1982). The Act states that: "The judicial officers shall hold a hearing to determine whether any conditions or combination of conditions set forth in subsection (c) of this section will reasonably assure
the appearance of such person as required and the safety of any other person and
the community." !d. § 3142 (f).
42.
United States v. Salerno, 481 U.S. 739, 741 (1987).
43.
ld. at 742. The Supreme Court in United States v. Salerno held that when
determining bail and pretrial release conditions courts must consider the following
statutorily enumerated factors: (1) a defendant's criminal charge, (2) a defendant's
prior record of conviction, (3) a defendant's community ties, and (4) a defendant's
history of drug abuse. ld. at 742-43.
44.
Gerstein v. Pugh, 420 U.S. 103, 114 (1975).
45.
441 U.S. at 539.
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While alternatives to systematic urine testing to detect
drug use could theoretically be employed, whether at the time
of the initial appearance or during periods of pretrial or postconviction release, the likelihood of discovering such use by
self-reporting or other measures is not as reliable as with urine
testing. 46 Arrestees are less likely to report their drug use,
knowing that their initial release may be adversely affected by
such an admission, or that future testing or participation in a
treatment program may be imposed as a condition of release.47 Against this reality, mandatory urine testing cannot
be considered excessive and is, therefore, not violative of the substantive due process test as articulated in Kennedy v. MendozaMartinez.48

B.

The Procedural Due Process Argument

To satisfy the requirements of procedural due process, the
process used to detect drug use must be sufficiently reliable so
as to ensure the accuracy of the results. 49 In most jurisdictions which have initiated mandatory pretrial drug testing, the
Enzyme Multiplied Immunoassay Technique (EMIT) system is
used to test the urine samples. Various courts have concluded
that the EMIT test is presumptively reliable and that the results are, therefore, admissible evidence. 50 Thus, once this
threshold assessment of the reliability of the test is made,
procedural due process is not offended so long as the proce46.
See discussion supra part II.
See, e.g., supra, studies cited in note 18 and the report and report findings,
47.
infra, notes 100 & 102.
48.
372 U.S. 144, 168-69 (1963). Even if other methods of detecting drug use
were just as reliable and could be accomplished by less intrusive measures, systematic pretrial urine testing could, nevertheless, be deemed reasonable. Although the
use of available alternative sources of information or evidence must be considered
when determining the reasonableness of a particular search, courts need not rule
that a restriction or condition is excessive merely because a less intrusive alternative exists. Accord Skinner v. Railway Labor Executives' Ass'n, 489 U.S. 602, 629
n.9 (1989); National Treasury Employees Union v. Von Raab, 816 F.2d 170, 178
(5th Cir. 1987), affd, 489 U.S. 656 (1989) (citing Colorado v. Bertine, 479 U.S. 367
(1987)).
National Treasury Employees Union v. Von Raab, 816 F.2d 170, 181 (5th
49.
Cir. 1987).
50.
See, e.g., Spense v. Farrier, 807 F.2d 753, 756 (8th Cir. 1986); Wykoff v.
Resig, 613 F. Supp. 1504, 1512 (N.D. Ind. 1985); Jensen v. Lick, 589 F. Supp. 35,
39 (D.N.D. 1984); Jones v. United States, 548 A.2d 35, 46 (D.C. 1988); Smith v.
State, 298 S.E.2d 482, 484 (Ga. 1983); see also Abell, supra note 10, at 947 n.19;
Mike Lawrence & Maria Hewitt, Accuracy and Reliability of Urine Drug Tests, 36
KAN. L. REV. 641 (1988); Rosen & Goldkamp, supra note 23, at 122 n.42.
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dures employed to protect the integrity of the urine samples
are adequate to insure the accuracy and reliability of the results which are presented to the court. 51

C.

The Fourth Amendment Search and Seizure Argument

The Fourth Amendment of the United States Constitution
guarantees, "[t]he right of the people to be secure in their persons, houses, papers and effects, against unreasonable searches
and seizures."52 This amendment protects persons, "against
certain arbitrary and invasive acts by officers of the government or those acting at their direction."53 The Supreme Court
has ruled that the collection and testing of urine samples is a
"search" under the Fourth Amendment. 54 In reaching this conclusion, the Court has stated that "[t]here are few activities in
our society more personal or private than the passing of
urine."55 In addition, the Supreme Court noted that the testing of urine samples can reveal other medical information
which may implicate privacy interests. 56
However, pretrial urine testing only transgresses the
Fourth Amendment if the taking of the samples for testing
purposes is unreasonable. 57 When determining reasonableness, the Supreme Court has stated that in each case it requires a balancing of "the intrusion [of a particular practice] on
the individual's Fourth Amendment interests against its promotion of legitimate governmental interests."58 Courts must
consider various factors when conducting this balancing test,
including: (1) the scope of the particular intrusion; (2) the man-

51.
Von Raab, 816 F.2d at 182.
52.
U.S. CONST. amend. IV.
53.
Skinner v. Railway Labor Executives' Ass'n, 489 U.S. 602, 613-14 (1989),
(citing Camara v. Municipal Court, 387 U.S. 523, 528 (1967)).
54.
Skinner, 489 U.S. at 617 ("Taking a blood or urine sample might also be
characterized as a Fourth Amendment seizure, since it may be viewed as a meaningful interference with the [individual's] possessory interest in his bodily fluids.").
!d. at 617-18 n.4. However, once an act is characterized as a "search," it becomes
unnecessary for Fourth Amendment purposes to also determine whether a seizure
occurred. !d.; see also National Treasury Employees Union v. Von Raab, 489 U.S.
656 (1989).
55.
Skinner, 489 U.S. at 617 (quoting Von Raab, 816 F.2d at 175).
56.
!d.
57.
!d. at 619 ("[T]he Fourth Amendment does not proscribe all searches and
seizures, but only those that are unreasonable."); see United States v. Sharpe, 470
U.S. 675, 682 (1985)); Schmerber v. California, 384 U.S. 757, 768 (1966) .
58.
Skinner, 489 U.S. at 619 (citing Delaware v. Prouse, 440 U.S. 648, 654
(1979)); United States v. Martinez-Fuerte, 428 U.S. 543 (1976).
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ner in which it is conducted; (3) the justification for initiating
it; and (4) the place in which it is conducted. 59
In criminal cases, searches or seizures will generally be
held reasonable only when "accomplished pursuant to a judicial
warrant issued upon [a showing of] probable cause."60 There
are many exceptions to the warrant requirement, however. 61
Pretrial drug testing has all of the ingredients of the non-criminal or administrative exception. The Supreme Court has determined that such searches are reasonable in the absence of
probable cause or some quantum of individualized suspicion
"where a Fourth Amendment intrusion serves special governmental needs beyond the normal need for law enforcement,"62
and when balanced against the individual's privacy expectations it would be "impractical to require a warrant or some
level of individualized suspicion in the particular context."63
The results of pretrial urine tests are only used for administrative and regulatory purposes, although admittedly within
the criminal justice setting. 64 Moreover, pretrial urine tests
are only conducted on those arrestees who consent to them.
While as a practical matter the refusal to provide an initial
sample may adversely impact an arrestee's pretrial release
status, the arrestee nevertheless retains the right of refusal. 65
Similarly, arrestees who are released subject to a condition of

59.
Bell v. Wolfish, 441 U.S. 520, 559 (1978).
60.
Skinner, 489 U.S. at 619 (citing Payton v. New York, 445 U.S. 573, 586
(1980)); Mincey v. Arizona, 437 U.S. 385, 390 (1978).
National Treasury Employees Union v. Von Raab, 489 U.S. 665 (1989)
61.
("While we have often emphasized, and reiterate today, that a search must be
supported, as a general matter, by a warrant issued upon probable cause, our
decision in Railway Labor Executives reaffirms the longstanding principle that neither a warrant nor probable cause, nor, indeed, any measure of individualized suspicion, is an indispensable component of reasonableness in every circumstance.")
(citations omitted).
62.
ld.
63.
ld. at 665-66; see also Skinner, 489 U.S. at 619 ("When faced with such
special needs, we have not hesitated to balance the governmental and privacy
interests to assess the practicality of the warrant and probable cause requirements
in the particular context.") (citations omitted); Willner v. Thornburgh, 928 F.2d
1185, 1187 (D.C. Cir.), cert. denied, 112 S. Ct. 669 (1991).
64.
Rosen, supra note 30, at 1191 ("[A]dministrative searches may be conducted
with the primary purpose of discovering criminal misconduct in order to impose
non-criminal sanctions involving loss of important rights and privileges or interests,
such as continued employment, the right to attend school, or imposition of civil
fines and penalties."); see also Griffin, 483 U.S. at 873-74.
65.
JOHN A. CARVER, U.S. DEP'T OF JUSTICE, DRUGS AND CRIME: CONTROLUNG
USE AND REDUCING RISK THROUGH TESTING (1986).

354

B.Y.U. JOURNAL OF PUBLIC LAW

[Volume 5

regular pretrial drug testing expressly consent to abide by this
condition, along with any other conditions imposed by the
court. 66
Furthermore, the results of pretrial urine testing cannot be
used in determining guilt on the underlying offense. 67 For example, in the District of Columbia, urine-test results are not
admissible on the issue of guilt on the underlying charge, although they can be used for other specified collateral purposes,
including use at perjury trials and contempt proceedings
brought against arrestees for violating conditions of release,
and for purposes of impeachment in any subsequent proceeding.ss
The government's legitimate interests in ensuring that
arrestees who are placed on pretrial release return to court as
instructed and do not commit new offenses while on release is
significantly advanced by pretrial drug testing. 69 The nexus
between the furtherance of these legitimate interests and mandatory drug testing is founded in the growing body of empirical
evidence showing a positive correlation between drug use and
crime and between drug use and failure to appear for subsequent court appearances. 70
On the other hand, whatever additional intrusion on the
privacy interests of arrestees is occasioned by pretrial drug
testing is minimal. 71 The persons being tested are already in

ld.
ld.
68.
D.C. CODE ANN. § 23-1303(d) (1981 & Supp. 1988); see also infra notes 8889; TOBORG ET AL., supra note 18, at 2.
69.
See, e.g., discussion supra part II.
See supra part II. In addition, drug use is itself a crime, and procedures
70.
like pretrial drug testing, which detect illegal drug use and discourage further
illegal use, help reduce the incidence of this crime. Thus, "[e]ven if no empirical
data existed that correlated drug testing and decreased criminal activity, drug
testing at least has the demonstrable result of lowering future drug use, a goal
which the government has a legitimate interest in advancing." Abell, supra note
10, at 951 (footnote omitted).
71.
Abell, supra, note 10, at 954; see also Stewart, supra note 14, at 75 ("What
is reasonable also requires 'balanc[ing] the nature and quality of the intrusion on
the individual's Fourth Amendment interests against the importance of the governmental interests alleged to justify the intrusion.' Use of urine is considered far less
intrusive than the drawing of blood, which requires an invasive technique.") (citation omitted). But see Skinner v. Railway Labor Executives' Ass'n, 489 U.S. 613,
626-28 (1989) (recognizing a privacy interest of constitutional dimensions in urine
testing, even though it does not involve an invasive act, but one which was nevertheless diminished and outweighed by the government's public safety interests); see
also Willner v. Thornburgh, 928 F.2d 1185, 1187 (D.C. Cir.), cert. denied, 112 S.
66.
67.
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custody, and this alone constitutes a substantial restriction on
the liberty rights of the arrestees. 72 Furthermore, a person
detained pursuant to a lawful arrest has already been seized
and can thereafter be compelled to give handwriting and blood
samples, voice exemplars, and to stand in line-ups. 73
Requiring the government either to obtain a warrant or to
develop individualized suspicion as predicates for pretrial urine
testing would severely hinder the government's ability to further the dual objectives derived from such testing. In order to
have test results available for arrestees' initial court appearances, when the issue of bail must be addressed-which occurs
within hours after an arrest-the tests must be conducted
expeditiously. The Supreme Court has recognized that the
government's interest in dispensing with the requirement of a
search warrant is at its strongest when "the burden of obtaining a warrant is likely to frustrate the governmental purpose
behind the search." 74 If the test results are not completed by
the time of required bail hearings, the government's legitimate
purposes are not only frustrated, but are totally defeated. Similarly, the systematic and expeditious processing of urine samples, and the mass screening of arrestees required if the government is not to be confined to relying on inaccurate measures
of recent drug use (such as self-reporting) in order to further
the purposes of drug testing, would be compromised if individualized suspicion were to be required before an arrestee could be
tested. 75
Ct. 669 (1991).
72.
Bell v. Wolfish, 441 U.S. 520, 537 (1978).
73.
National Treasury Employees Union v. Von Raab, 816 F.2d 170, 181 (5th
Cir. 1987), affd, 489 U.S. 656 (1989) (quoting United States v. Wade, 388 U.S.
218, 222 (1967)).
74.
Skinner v. Railway Labor Executives' Ass'n, 489 U.S. 613, 623 (1989) (quoting Camara v. Municipal Court of San Francisco, 387 U.S. 523, 533 (1967)).
75.
One commentator has observed:
[P]retrial urinalysis specifically avoids "individualized suspicion" analysis
by requesting all persons in lock-up to participate. Further, the liberty
and property interests-employment versus the recognized government
interest in setting bail-are so unrelated that the "individualized suspicion" need not be formed. The results of pretrial urinalysis testing are not
used to deny or terminate employment. Nor are they used to effect an
arrest and thus seize a person, thereby limiting liberty. On the contrary,
arrestees submit to testing voluntarily to provide information related to
bail. No individual is singled out as a suspect of unlawful behavior or as
a danger to the community; thus individualized suspicion is never formed.
Therefore, the intrusion into liberty or property interests need not be
balanced against individualized "reason to believe" because this analysis
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In sum, the government's legitimate interests in ensuring
that arrestees who are released pending trial return to court as
instructed and refrain from committing new offenses while on
conditional release are significantly advanced by pretrial urine
testing. On the other hand, the intrusion on the Fourth
Amendment rights of arrestees which occurs from the taking of
the urine samples, prior to an initial appearance or as a condition of pretrial release, is minimal. Balancing the competing
interests of the government and arrestees in the context of
pretrial urine testing tilts the scales heavily in favor of the
government and justifies the testing of all arrestees without
first requiring that the government acquire a warrant or make
a showing of individualized suspicion. 76

D.

The Privilege Against Self-Incrimination Argument

The Fifth Amendment privilege against self-incrimination
"only protects an accused from being compelled to testify
against himself, or otherwise provide the government with
evidence of a testimonial or communicative nature.'m The information discovered from a drug test does not reveal any knowledge that the person tested was required to communicate. 78
Moreover, pretrial drug test results are used simply to aid the
court in selecting appropriate release conditions. 79 Therefore,

simply does not apply.
Abell, supra note 10, at 955 (citations omitted). But see Rosen & Goldkamp, supra
note 23, at 171 (Absent consent, implementation of mass urine testing programs
may be impossible if pre-bail drug testing is limited by requiring reasonable, individualized suspicion.).
76.
Skinner, 489 U.S. at 626-28; see also Willner v. Thornburgh, 928 F.2d 1185,
1191 (D.C. Cir.), cert. denied, 112 S. Ct. 669 (1991).
See United States v. Dionisio, 410 U.S. 1, 7 (1973) (producing voice exem77.
plars does not violate the privilege against self-incrimination); Gilbert v. California,
388 U.S. 263, 266-67 (1967) (requiring handwriting samples does not violate the
privilege against self-incrimination); United States v. Wade, 388 U.S. 218, 221-23
(1967) (requiring arrestees to stand in a lineup does not violate the privilege
against self-incrimination); Schmerber v. California, 384 U.S. 758, 760 (1966)
(requiring an arrestee to furnish blood samples does not violate the privilege
against self-incrimination). In the case of pretrial urine testing, as in these cases,
an arrestee's testimonial capacities are in no way implicated. Indeed, "[an
arrestee's] participation, except as a donor, [is] irrelevant to the results of the test,
which depend on chemical analysis and on that alone." Id. at 765 (footnote omitted).
Schmerber, 384 U.S. at 765.
78.
79.
The District of Columbia pretrial drug test results are also routinely used
by judges when imposing sentences. Since guilt has already been established, there
is nothing legally impermissible about this practice. See id. at 761 (holding that
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the Fifth Amendment privilege against self-incrimination cannot be considered a bar to mandatory pretrial urine testing.

E.

The Sixth Amendment Right to Counsel Argument

The Sixth Amendment guarantees all criminal defendants
the right to the assistance of counsel. 80 The right attaches at
the "time adversary judicial proceedings have been initiated
against [the accused]."81 Such proceedings have been characterized by the Supreme Court as "critical stage[s] of the
prosecution."82 While the Supreme Court has not yet ruled on
the specific issue of whether the right to counsel attaches when
urine samples are collected or when pretrial drug testing is
conducted, the Court's precedents clearly suggest that neither
of these events occurs during a "critical stage in the prosecution." Like the post-arrest taking or testing of blood, fingerprints, clothing, hair, and the like, the denial of the right to
have counsel present when the urine samples are taken or
when the pretrial drug tests are performed does not violate a
defendant's Sixth Amendment rights, "since there is minimal
risk that his counsel's absence at such stages might derogate
from his right to a fair trial."83 However, even if arrestees had
the right to have their attorneys present, the Sixth Amendment
would not preclude the government from conducting pretrial
urine tests. 84

even when the non-testimonial evidence is used to discover evidence that can be
used to prosecute the individual, there is no violation of the privilege against selfincrimination). The test results merely provide additional information for the
sentencing judge to consider when assessing whether convicted individuals will
comply with conditions of probation or pose a danger to the public if a probationary sentence is imposed. See EvANS, supra note 20, at 18.
80.
U.S. CONST. amend. VI.
81.
Kirby v. Illinois, 406 U.S. 682, 688 (1972).
Simmons v. United States, 390 U.S. 377, 382-83 (1967).
82.
83.
United States v. Wade, 388 U.S. 218, 227-28 (1967); see, e.g., Gilbert v.
California, 388 U.S. 263 (1967) ("The taking of the [handwriting] exemplars was
not a 'critical' stage of the criminal proceedings . . . . "); Schmerber v. California,
384 U.S. 758, 766 (1966) (no right to counsel at the post-arrest drawing of a blood
sample because "[n]o issue of counsel's ability to assist [the defendant] in respect
of any rights he did possess is presented."); see also 3 JOSEPH G. COOK, CONSTITUTIONAL RIGHTS OF THE ACCUSED § 7:3 (2d ed. 1986 & Supp. 1989).
84.
See, e.g., Wade, 388 U.S. at 237-38.
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EXISTING PROGRAMS FOR DRUG TESTING OF ARRESTEES

The Washington, D.C., Program 85

Beginning in 1984, a comprehensive pretrial drug testing
program for adult defendants was implemented in the District
of Columbia, funded by the National Institute of Justice (NIJ).
When Federal funding for the program expired in 1986, the
program was maintained through local funding. The testing
program is operated by the District of Columbia Pretrial Services Agency (PSA), an independent agency of the District of
Columbia Government. The PSA is charged by law with the
responsibility for (1) interviewing all adult arrestees to determine their eligibility for pretrial release; (2) making recommendations as to appropriate terms and conditions for release in all
criminal cases; and (3) monitoring compliance with release
conditions for all defendants, except those released on surety
bonds. 86
PSA attempts to test all adult arrestees coming through
the District of Columbia's Superior Court lockup for the presence of selected drugs in their urine, prior to their initial court
appearances. The tests will detect the presence of opiates (primarily heroin), cocaine, PCP, amphetamines, and
methadone. 87 The urine samples are collected in the presence
of a PSA worker. 88 The samples are then taken by PSA staff

85.
D.C. CODE ANN. § 23-1303 (1981 & Supp. 1988). While not specifically authorizing drug testing, the statutory basis for the District of Columbia's testing
program rests in this section and the other sections (23-1301 to 23-1332) of Chapter 13 of Title 23 of the D.C. Code [Pretrial Services Agency and Pretrial Detention]. A more complete description of the District of Columbia drug testing
program can be found in articles by John A. Carver, Esq., Director of the District
of Columbia Pretrial Services Agency. See John A. Carver, Pretrial Drug Testing:
An Essential Step in Bail Reform, 5 B.Y.U. J. PuB. L. ??? (1991); CARVER, supra
note 65. For other evaluations of the District of Columbia program see TOBORG &
BErLASSAI, supra note 29 and PRETRIAL RELEASE, supra note 29.
86.
TOBORG & BELLASSAI, supra note 29, at 1.
87.
Beginning in 1986, the District of Columbia Pretrial Services Agency (PSA)
also began testing all juvenile arrestees for the same selected drugs except methadone. TOBORG AND BELLASSAI, supra note 29, at 5.
88.
The Supreme Court considered whether urine samples are taken under the
direct supervision of a monitor as a relevant factor when assessing the degree of
the intrusion on the individual's privacy rights. Skinner v. Railway Labor
Executives' Ass'n, 489 U.S. 613, 626 (1989). While the Court stated that the lack
of such monitoring lessened the extent of the intrusion, it nevertheless recognized
"the desirability of such a procedure to ensure the integrity of the sample." ld.
Moreover, the Skinner Court, in the context of employee testing, concluded that the
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from the court lockup directly to PSA's laboratory-located in
the same building-for analysis, using the EMIT system. 89
Test results are made available that same day-usually within
1-2 hours-to PSA's in-court representatives, who are present
at the arrestee's initial court appearance to make the test results available to the sitting judge or commissioner and to
make pretrial release recommendations to the court.
Before this program began, the only release option specifically tailored to the needs of drug users had been referrals for
treatment. With the advent of the drug testing program, however, a new release alternative became available for drug-using
defendants, namely, placement in PSA's periodic urine-testing
program. 90 If an individual repeatedly tests positive while on
pretrial release and the positive results are confirmed by a
second EMIT test, the defendant may be considered in violation
of a condition of his release or held in contempt of court for
failure to comply with a court-ordered condition of release. A
series of graduated sanctions can then be imposed, ranging
from more frequent drug testing to additional release
conditions-including the posting of a money bond-and the
imposition of a contempt of court citation resulting in a fine or
a prison sentence.

nature of the industry was the most important factor to consider when calculating
the reasonableness of employees' expectations of privacy. ld. at 627. Since the
industry in Skinner (the railroad industry) "is regulated pervasively to ensure
safety, a goal depeadent, in substantial part, on the health and fitness of covered
employees," the Court held that the justifiable expectations of privacy for such
employees is minimal. ld. at 627-28.
In the context of pretrial testing, arrestees have been charged with violating a
criminal statute and are already in custody ,-ihen the urine samples are taken.
Furthermore, the arrestees do not have access to a private bathroom when the
samples are collected during their detention. Under these circumstances, arrestees'
reasonable expectations of privacy-at least as to their urine-cannot be considered
substantial. And when weighed against the compelling government interest to
determine whether arrestees are drug users for the purpose of setting bail, the
government's interests are clearly superior. Accordingly, the presence of the PSA
monitor is not so intrusive as to make the collection of the urine samples an
unreasonable search or seizure.
89.
The District of Columbia Court of Appeals has held "that [the Enzyme Multiplied Immunoassay Technique] EMIT test results are presumptively reliable and
generally admissible into evidence in every case." Jones v. United States, 548 A.2d
35, 46 (D.C. 1988) (citation omitted). In Jones, the government was allowed to
introduce evidence of a positive pre-arraignment urine test to impeach the
defendant's testimony that he did not know the substance he was charged with
possessing was cocaine.
90.
Judges also use the information in fashioning appropriate sentences.
TOBORG & BELLASSAI, supra note 29, at 2; see also supra notes 68 & 79.

360

B.Y.U. JOURNAL OF PUBLIC LAW

[Volume 5

Though it began as a research program, the PSA drug
testing program now comprises an integral part of the pretrial
(as well as the post-conviction) decision-making process in the
District of Columbia's Superior Court. During the period from
the program's implementation on March 5, 1984, until January
1, 1988, some 57,000 criminal defendants in the District of
Columbia program were tested. 91 In 1988 alone, the agency
conducted 35,000 prisoner interviews, sent out 60,000 court
appointment letters, and performed more than 50,000 drug
tests. 92
B.

Other Local Programs

The Washington, D.C., drug testing program has served as
a model for a number of other programs around the country. 93
Beginning in 1987, the United States Department of Justice's
Bureau of Justice Assistance (BJA), seeking to replicate and
test the "D.C. model" in other jurisdictions, contracted with the
Pretrial Services Resource Center in Washington, D.C., to assist BJA in selecting from among applicant jurisdictions a limited number of sites to implement pretrial drug testing programs, and to provide technical assistance to those sites during
the period when discretionary Federal funding was provided. 94
Since then, seven such programs have been initiated: Pima
County, Arizona (Tucson, beginning in 1987); Multnomah
County, Oregon (Portland, beginning in 1987); New Castle

91.
Stewart, supra note 14, at 73.
92.
David S. Broder, D.C. Pretrial Agency Is a Small but Vital Cog in Wheels
of Justice, WASH. POST, May 28, 1989, at Cl.
93.
The Office of National Drug Control Policy has emphasized the importance,
at both the State and Federal levels, of devising workable measures of accountability to ensure that limited funds go to those programs that have achieved
demonstrable results. See, e.g., OFFICE OF NATIONAL DRUG CONTROL PoUCY, UNDERSTANDING DRUG TREATMENT (WHITE PAPER) 2-3 (1990); STATUS REPORT, supra note
4, at 1.
94.
PRETRIAL SERVICES RESOURCE CENTER, U.S. DEP'T OF JUSTICE, ESTIMATING
THE COSTS OF DRUG TESTING FOR A PRETRIAL SERVICES PROGRAM 1 (1989). The
Resource Center also provides technical assistance to local jurisdictions using
Federal funds from the Bureau of Justice Assistance's (BJA) block grant program
to implement pretrial drug testing. The Resource Center has also prepared two
other monographs, still in draft form and under review by BJA: "Integrating Drug
Testing into a Pretrial Services System," an implementation guide for program
administrators, and "Interim Guidelines for Pretrial Drug Testing," which provides
a framework for initiating and operating a pretrial drug testing program. The
American Probation and Parole Association is also working with BJA to develop
guidelines for post-conviction drug testing.
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County, Delaware (Wilmington, beginning in 1987 and terminated shortly thereafter); Prince George's County, Maryland
(beginning in 1988); Maricopa County, Arizona (Phoenix, beginning in 1988); Milwaukee County, Wisconsin (beginning in
1989); and Los Angeles County, California (beginning in 1990
but involving only pretrial supervision testing). Because of
funding problems, several jurisdictions have subsequently limited or discontinued their pre-initial appearance testing programs.95
While these are the only federally-funded programs that
have employed-at least initially-pre-arraignment drug testing on a widespread basis, a number of other state and local
programs use drug testing on a limited basis at different stages
of their criminal justice process. A nationwide survey of state
and local pretrial services programs conducted by the Pretrial
Services Resource Center in 1990 revealed that 72 of the 180
programs responding indicated that pretrial drug testing is
conducted in some capacity. Of these 72 programs, 58 indicated
that testing is available only as a condition of release and on a
selective basis. 96
Another survey has recently been conducted by the National Criminal Justice Association (NCJA), as part of their study
to determine the fiscal impact on States of the drug testing
requirement called for in the National Drug Control Strategy.97 As of January 31, 1991, twenty-four States and the Dis-

95.
While not as exhaustive as the studies of the Washington, D.C. program,
evaluations have been prepared for some of the other demonstration sites. See
STEFAN KAPSCH & LOUIS SWEENY, U.S. DEP'T OF JUSTICE, MULTNOMAH COUNTY
DETECTION AND MONITORING OF DRUG-USING ARRESTEES, EVALUATION FINAL REPORT (REVISED) (1990); JOHN S. GoLDKAMP ET AL., U.S. DEP'T OF JUSTICE, THE
UTILITY OF DRUG TESTING IN THE ASSESSMENT OF DEFENDANT RISK AT THE PRETRIAL RELEASE DECISION, FINAL REPORT (1989); JOHN S. GoLDKAMP ET AL., U.S.
DEP'T OF JUSTICE, MEASURING THE IMPACT OF DRUG TESTING AT THE PRETRIAL
RELEASE STAGE: PRETRIAL DRUG TESTING IN MILWAUKEE COUNTY, NEW CASTLE
COUNTY AND PRINCE GEORGE'S COUNTY: PRELIMINARY REPORT WITH EVALUATION
UPDATE FROM THE PIMA COUNTY PROGRAM (1989).
96.
Conversation with the Pretrial Services Resource Center, Washington, D.C.,
February 1991.
The National Criminal Justice Association (NCJA) is a special interest
97.
group based in Washington, D.C., that represents States on crime control and
public safety matters and provides staff support to the National Governors
Association's Committee on Justice and Public Safety. The impact study provision
was incorporated into the State-Justice appropriations bill, H.R. 2991, lOlst Cong.,
1st Sess. (1989), which was signed into law by President Bush on November 21,
1989. The study is expected to be completed by the end of 1991. The study is
being funded by the National Institute of Justice.
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trict of Columbia had responded to the survey. Preliminary
results suggest that drug testing programs for probationers and
parolees are most common, with at least some testing of those
populations in twenty-three of the twenty-five jurisdictions; in
addition, seventeen states reported testing individuals who
were under some other form of conditional release (either pretrial or post-conviction, or both). Nineteen states also reported
testing individuals who were incarcerated, and fifteen reported
testing inmates in other correctional facilities, such as "boot
camps." Thirteen states reported testing arrestees, and ten
states reported testing arrestees who had been detained following their initial court appearance; however, early analyses
suggest that much of the reported testing of these populations
occurs as part of the nationwide Drug Use Forecasting (DUF)
program and not as a sanction or as a monitoring measure. A
number of states reported having existing testing authority but
no testing programs; most often this authority covers probation
and parole populations, followed by the testing of individuals
on other forms of conditional release (either pretrial or postconviction), prison inmates, and persons in other types of correctional facilities. 98

C.

Drug Testing Programs in the Federal Courts

Section 7304 of the Anti-Drug Abuse Act of 1988, 99 required the Director of the Administrative Office of the United
States Courts ("Administrative Office") to establish a demonstration program of mandatory drug testing of criminal defendants in eight Federal judicial districts. The program began
January 1, 1989, and concluded two years later, in the following districts: the Middle District of Florida; the Southern District of New York; the Eastern District of Michigan; the Western District of Texas; the District of Nevada; the District of
Minnesota; the District of North Dakota; and the Eastern District of Arkansas. As of March 1991, all of the demonstration
sites were continuing the pretrial testing programs with funding from the Administrative Office, but only Arkansas was continuing to test post-conviction releasees on a comprehensive
basis. 100 To the extent feasible, testing was to be completed
98.
NATIONAL CRIMINAL JUSI'ICE ASSOCIATION, STATUS OF NCJA RESEARCH ON
!S:'l'UES AFFECTING DRUG TESTING OF CRIMINAL JUSTICE POPULATIONS IN THE
STATES (DRAFT REPORT) 3-5 (1991).
99.
Pub. L. No. 100-690, 102 Stat. 4181 (codified at 21 U.S.C. § 1501 (1988)).
Conversation with the Administrative Office of the United States Courts,
100.
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prior to the defendant's initial appearance before a judge or
magistrate, and the results of the test were to be included in
the bail report presented to the judicial officer. If the court
ordered the release of the defendant before trial, under title 18,
Section 3142(c) of the United States Code, it was to order further periodic testing as a condition of release. 101
The legislation which established the demonstration program further provided that for felony offenses occurring or
completed on or after January 1, 1989, it was to be an additional, mandatory condition of probation or unsupervised release that defendants refrain from the illegal use of any controlled substances and submit to periodic urinalysis to detect
drug use at least once every sixty days. However, the testing
requirement could be suspended if all of a defendant's drug
tests were negative after at least one year of testing. 102
The findings of the demonstration program support other
studies showing that urine testing is substantially more reliable than self-reporting in identifying recent drug users. 103
Moreover, during the length of the program, there were no
formal legal challenges to the constitutionality of pretrial drug
testing in the federal system. 104 In its final report to Congress on the demonstration project, the Administrative Office
recommended the expansion of pretrial urine testing, both to
enhance the ability of judicial officers to assess the dangerousness of defendants for bail-setting purposes and to enhance the
current methods of post-conviction drug testing administered in
the federal court system. 105
V.

USING DRUG TEST RESULTS TO INCREASE THE EFFECTIVENESS AND FAIRNESS OF THE CRIMINAL JUSTICE SYSTEM

The results of urine-testing programs can be used at vari-

Washington, D.C., March 1991.
ADMINISI'RATIVE OFFICE OF THE UNITED STATES COURTS, FINAL REPORT ON
101.
THE DEMONSTRATION PROGRAM OF MANDATORY DRUG TESI'ING OF CRIMINAL DEFENDANTS (1991) [hereinafter MANDATORY DRUG TESTING].
102.
ld.
103.
!d. at iii. "Pretrial testing prior to the initial appearance identifies 31% of
all tested defendants in the eight pilot districts as drug users. This compares with
24% of defendants nationally who admit to a substance abuse problem or a recent
history of substance abuse during the pretrial services interview." ld.; see also
supra notes 18 & 47.
104.
MANDATORY DRUG TESTING, supra. note 101, at iii, 18.
MANDATORY DRUG TESTING, supra note 101, at iii-iv, 78.
105.
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ous stages of the criminal justice process to promote both fairness and effectiveness.

A. Pretrial Monitoring
One recent study concluded there are at least four reasons
to drug test in the criminal justice system: (1) to detect those
who have recently used drugs; (2) to identify chronic users; (3)
to monitor and deter drug use among those under the authority
of the criminal justice system; and (4) to estimate national and
local drug-use trends among criminal justice system populations.106 Testing immediately after arrest, coupled with regular drug testing of those who test positive and are then conditionally released, can further each of these purposes. For example, the District of Columbia's program, and those patterned
after it, use arrestees' initial urinalysis results to aid judges in
determining conditions of pretrial release, and the results of
those defendants who are periodically tested as a condition of
pretrial release are used to monitor compliance with release
conditions imposed by the court. 107
For pre-trial testing programs to have a meaningful deterrent value, however, it is essential that they be able to respond
quickly when conditions of release are violated. 108 This responsiveness has been part of the program design in the District of Columbia since its inception. 109 However, many judges
who reported in 1985 that they often held bail revocation and
contempt hearings for condition of release violations told the
District of Columbia study team in 1989 that they no longer
did so as frequently, because of the pressure of growing court
106.
Wish & Gropper, supra note 17, at 324. See also Rosen, supra note 30, at
1245-46 (identifying three ways to utilize urinalysis in probation-as an assessment
tool, as a surveillance and monitoring mechanism, and as a deterrent device).
107.
The District of Columbia has also used its drug-test information to assess
drug-use trends and to develop therefrom appropriate planning and prevention
strategies. For exam~le, the juvenile urine-testing program resulted from the ongoing adult lockup test results, which disclosed high rates of drug use among young
adults. These findings created an incentive for earlier interventions, particularly
before juveniles entered the adult criminal justice system. In addition, because the
results of the lockup testing of adult arrestees showed surprisingly high rates of
cocaine and PCP use, a greater percentage of treatment and prevention resources
were directed to abusers of those drugs. TOBORG ET AL., supra note 18, at 5.
BUREAU OF JUSTICE ASSISTANCE, URINALYSIS AS PART OF A TREATMENT AL108.
TERNATIVES TO STREET CRIME (TASC) PROGRAM (MONOGRAPH) 4 (1988).
CARVER, supra note 65 ("If the program is to have the intended deterrent
109.
effect, defendants must know that violations will be detected and punishment will
follow.").
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dockets. Judges in the Portland program have shown a similar
reluctance to hold show cause hearings. 110 Notwithstanding
the demands such oversight places on judges, it is important
that some type of sanction be applied at the earliest indication
of noncompliance. Such a policy is consistent with research
findings that even failing to appear for the first post-release
urine test is a significant indicator of subsequent pretrial misconduct, for either rearrest or failure to appear.lll These
sanctions, at least initially, need not result in the revocation of
defendants' release status. There should, however, be a graduated system of sanctions available, and the sanctions which are
imposed should be measured to fit the circumstances of the violation and the offender. 112
The benefits of pretrial urinalysis programs extend beyond
the criminal justice arena to the general community and to the
drug-abusing offenders themselves. 113 Such programs provide
the government and the public with a fast and reliable tool for
detecting and deterring recurring drug use-and the criminal
activity that often accompanies such use-for those on pretrial
release. They help judges by giving them information about defendants that is of great value in making reasoned and objective decisions. And, they also help the defendants required to
participate in the testing programs. For example, such programs allow for more flexible bail-setting at the pretrial stage.
Moreover, they help identify those defendants who need drug
treatment, can coerce them into treatment, and thereafter give
them a continuing incentive to stay in treatment. 114 At the
same time, pretrial testing programs enhance the public safety
by reducing the number of drug-using defendants on pretrial

TOBOIW & BELLASSAI, supra note 29, at 19; KAPSCH, & SWEENY, supra note
95, at 6.16.
111.
Visher, supra note 14, at 325, 330.
112.
!d. Compare NORVAL MORRIS & MICHAEL TONRY, BETWEEN PRISON AND
110.

PROBATION: INTERMEDIATE PUNISHMENTS IN A RATIONAL SENTENCING SYSTEM 8
(1990), wherein the authors argue persuasively for "an enriched range of pun-

ishments better suited to the diversity of crime and criminals to be sentenced, and
with intermediate punishments being more extensively imposed and more determinedly enforced for the better protection of the community and the larger achievement of justice."
113.
While this article confines itself to urine testing, a recent comparison of
different drug testing methods (including different methods of urine testing and
hair testing) and their applications in criminal justice systems, as well as a discussion of some of the legal and ethical issues raised by the tests, can be found in
Wish & Gropper, supra note 17.
114.
See Abell, supra note 10, at 956.
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release.
B.

Monitoring for Treatment Purposes

The majority of drug users do not need drug treatment, but
they often do need the threat of social, legal or employer sanctions to motivate them to stop on their own. 115 For these persons, pretrial urine-testing alone, without referral to treatment,
is often sufficient to prompt them to stop using drugs. 116 Similarly, for drug users who need treatment, it is frequently trouble with the law that forces them into treatment. In fact, according to the 1989 Treatment Outcome Prospective Study
(TOPS) done at the Research Triangle Institute, as many as
one out of two people who enter public drug treatment programs were under either direct or indirect legal pressure to do
so.117

At present, there remains a shortage of public drug treatment slots in this country. Urine test results can help make the
criminal justice system more effective by allocating those slots
to the individuals who need them most. Urine-testing programs
at the bail-fixing stage can also lead to earlier and more extended interventions. Moreover, different forms of drug abuse
require different treatment modalities, and urine-testing programs can help match those individuals who need treatment
with the most appropriate program. Continued drug-testing as
a condition of release can help to keep a drug abuser in
treatment for a longer time, and virtually all studies agree that
the longer an addict receives treatment, the better his or her
chances are for long-term success. 118 Nor are the prospects for
success diminished by the threat of legal sanctions. Indeed, research has determined that those under legal pressure to undergo treatment do as well as, or better, than those who seek
treatment on their own. 119

See UNDERSTANDING DRUG TREATMENT, supra note 93, at 4.
In the District of Columbia's urine-testing program, PSA
studies show that while 43 percent of the tests ordered for those on pretrial release in 1988 came up positive for at least one of the five drugs,
more than 700 people who were drig users when first arrested went
through the entire series of court-ordered post-arrest tests without another
positive drug finding.
Broder, supra note 92, at C4.
See UNDERSTANDING DRUG TREATMENT, supra note 93, at 10.
117.
118.
UNDERSTANDING DRUG TREATMENT, supra note 93, at 11, 25.
UNDERSTANDING DRUG TREATMENT, supra note 93, at 11, 25; see also HARRY
119.

115.
116.
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Post-Conviction Monitoring

While drug testing is of vital importance at the pretrial
stage to assess risks associated with release pending final adjudication of criminal cases, it is of equal importance to the effective functioning of probation and parole programs. In fact, if
post-conviction release immediately follows a period of pretrial
testing during which the arrestee abstained from drug use, or
the post-conviction release occurs within a relatively short time
thereafter, the likelihood of successful post-conviction release is
enhanced. As stated in the initial National Drug Control
Strategy:
Probation, like parole, court-supervised treatment, and some
release programs, should be tied to a regular and rigorous
program of drug testing in order to coerce offenders to abstain
from drugs while integrating them back into the community.
Such programs make prison space available for those drug
offenders we cannot safely return to the streets. But unless
they rigidly enforce drug abstinence under the threat of incarceration, these efforts lose their teeth. Drug tests should be a
part of every stage of the criminal justice process-at the time
of arrest and throughout the period of probation or incarceration, and parole-because they are the most effective way of
keeping offenders off drugs both in and out of detention. 120

For those defendants who initially test positive for drug
use, but thereafter cease their use and are then sentenced to
probation, it is important that they continue on a urine testing
program as a condition of their probation (or parole). A 1986
study for the Administrative Office of the United States Courts
indicated that in the absence of such testing, even probation
officers in intensive supervision programs cannot identify
which of their probationers are currently abusing drugs. 121
There is some evidence that post-conviction urine testing
K. WEXLER ET AL., U.S. DEP'T OF JUSTICE, A CRIMINAL JUSTICE SYSfEM STRATEGY
FOR TREATING COCAINE-HEROIN ABUSING OFFENDERS IN CUSTODY 5-6 (1988);
James Q. Wilson, supra note 14, at 537; Dean R. Gerstein, & Henrick J. Harwood,
Treating Drug Problems, 1 INsr. OF MED. 9-11 (1990).
120.
NATIONAL DRUG CONTROL STRATEGY I, supra note 5, at 26.
ERIC D. WISH ET AL., U.S. DEP'T OF JUSTICE, IDENTIFYING DRUG USERS AND
121.
MONITORING THEM DURING CONDITIONAL RELEASE 6 (1988) (citing ERIC D. WISH ET
AL., ADMINISTRATIVE OFFICE OF THE U.S. COURTS, EsriMATES OF DRUG USE IN
INTENSIVE SUPERVISION OF PROBATIONERS: RESULTS OF A PILOT STUDY, FEDERAL
PROBATION (1986)).
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programs, along with increasing the effectiveness of probation
and parole, can also reduce recidivism rates. For example, an
analysis of the California Civil Addict Program found that
heroin-using parolees who were urine-tested as part of their
supervision had lower rates of criminality than otherwise similar parolees who received no supervision or supervision without
testing. 122 On the other hand, a National Institute of Justice
study shows that among serious drug users who were also
involved in criminal activity, those under post-conviction supervision without urine testing and those under no legal supervision at all commit crimes and use drugs at about the same
rate. 123 Thus, empirical research supports the notion that
urine testing is an essential component of post-conviction supervision for individuals at high-risk for continued drug use.
VI.

CONCLUSION

The magnitude of the problems created by drug use is
staggering. Many of our nation's children are being born physically and mentally impaired because their mothers used drugs
during pregnancy. Intolerable numbers of children are being
abandoned, and in other ways abused and neglected, by their
drug abusing parents. The streets of many of our cities and
even our smaller towns are flowing with blood, at least in part
because of drug involvement by the American citizenry. As a
result, many of our fellow citizens live in a constant state of
fear in their neighborhoods.
Our criminal justice system and our society as a whole
need as many weapons as can reasonably be deployed if, as a
Nation, we are to prevail in the war against drugs. Each of the
National Drug Control Strategies has addressed the many
challenges we face and has identified the necessary steps we
must take to meet those challenges. One step that has been
encouraged in each Strategy has been the use of drug testing
through urinalysis at all stages of the criminal justice process,
including the pretrial stage. Such testing is constitutionally
sound and satisfies traditional notions of bail and pretrial re-

122.
ld. at 16.
123.
Christy A. Visher, Incorporating Drug Treatment in Criminal Sanctions,
N.I.J. REP., Summer 1990, at 3 (citing M.D. ANGLIN ~"'' AL., U.S. DEP'T OF JUSTICE,
REEXAMINING THE EFFECTS OF PROBATION AND PAROLE ON NARCOTICS ADDICTION
AND PROPERTY CRIME (FINAL REPORT) (1989)). NIJ is now considering field experiments to evaluate the effect of urine testing of those on probation and parole. ld.
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lease. At the pretrial stage, testing serves the interest of the
public by quickly detecting drug use, which is often related
both to criminal activity and failure to appear for scheduled
court appearances. It serves the interest of the judiciary by
giving judges more objective data on which to base their bail
and pretrial supervision decisions. And, it benefits arrestees by
providing an additional bail option and pretrial monitoring
mechanism, and also by coercing many of them to get drug
treatment and to stay in treatment for an extended period,
thus improving their chances for long-term success.
As we continue the battle against illegal drugs, pretrial
drug testing (and indeed drug testing throughout the entire
criminal justice system), constitutes an important weapon. It
will, therefore, continue to be an essential component of the
Bush Administration's National Drug Control Strategy.

